VANESSA DELGADO: Open Payments
NPI 1780051227 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,142 in 136 payments from 15 companies in 2025. Trend: 2023 $1,627 · 2024 $1,086 · 2025 $3,142
Food & beverage: $3,142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $908 |
| Madrigal Pharmaceuticals | 30 | $895 |
| Janssen Biotech, Inc. | 12 | $338 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $215 |
| Celltrion USA Inc. | 7 | $201 |
| Braintree Laboratories, Inc. | 8 | $183 |
| Ardelyx, Inc. | 5 | $117 |
| PFIZER INC. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| EVOKE PHARMA, INC. | 2 | $38 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, SKYRIZI, VEGZELMA, LINZESS, ENTYVIO, SUFLAVE.
Industry payments across MI — which companies pay providers there.
